Sakka Samir G, Reinhart Konrad, Meier-Hellmann Andreas
Department of Anesthesiology and Intensive Care Medicine, Friedrich-Schiller-University of Jena, Jena, Germany.
Chest. 2002 Nov;122(5):1715-20. doi: 10.1378/chest.122.5.1715.
Measurement of the indocyanine green plasma disappearance rate (ICG-PDR) has been proposed as a clinical tool for the assessment of liver perfusion and function in transplant donors as well as a prognostic marker. In this study, we analyzed the prognostic value of the ICG-PDR in critically ill patients.
Retrospective analysis.
Operative ICU of a university hospital.
We analyzed 336 critically ill patients (120 female and 216 male; age range, 10 to 89 years; mean +/- SD age, 53 +/- 19 years) who were treated in our ICU between 1996 and 2000. All these patients were hemodynamically monitored by the transpulmonary double indicator (thermo-dye) dilution technique. Each patient received a femoral artery sheath through which a 4F flexible catheter with an integrated thermistor and fiberoptic was advanced into the abdominal aorta. The ICG-PDR was calculated using a computer system. For each measurement, 15 to 17 mL of 2% indocyanine green were injected in a central vein. Statistical analysis using the lowest value of the ICG-PDR in each individual showed that it was significantly lower in nonsurvivors (n = 168) than in survivors (n = 168) [median, 6.4%/min vs 16.5%/min; p < 0.001]. Sensitivity and specificity with respect to survival was analyzed by receiver operating characteristics. The area under the curve (AUC) as a measure of accuracy was 0.815 when using lowest the ICG-PDR in each patient. For ICU admission (data from 178 patients), AUCs were 0.680 for the APACHE (acute physiology and chronic health evaluation) II, 0.755 for the simplified acute physiology score (SAPS) II, and 0.745 for the ICG-PDR.
The ICG-PDR as a marker of liver perfusion and function is a good predictor of survival in critically ill patients: mortality increased with lower ICG-PDR values, and nonsurvivors had significantly lower ICG-PDR values than survivors. Sensitivity and specificity of the ICG-PDR on ICU admission with respect to survival was comparable to that of APACHE II and SAPS II scores.
吲哚菁绿血浆消失率(ICG-PDR)的测量已被提议作为评估移植供体肝脏灌注和功能的临床工具以及一种预后标志物。在本研究中,我们分析了ICG-PDR在危重病患者中的预后价值。
回顾性分析。
一所大学医院的手术重症监护病房。
我们分析了1996年至2000年期间在我们重症监护病房接受治疗的336例危重病患者(120例女性和216例男性;年龄范围10至89岁;平均±标准差年龄,53±19岁)。所有这些患者均通过经肺双指示剂(热染料)稀释技术进行血流动力学监测。每位患者均置入股动脉鞘管,通过该鞘管将带有集成热敏电阻和光纤的4F柔性导管推进至腹主动脉。ICG-PDR使用计算机系统计算。每次测量时,在中心静脉注射15至17 mL 2%的吲哚菁绿。对每个个体的ICG-PDR最低值进行统计分析显示,非幸存者(n = 168)的该值显著低于幸存者(n = 168)[中位数,6.4%/分钟对16.5%/分钟;p < 0.001]。通过受试者工作特征分析了ICG-PDR对生存的敏感性和特异性。以曲线下面积(AUC)作为准确性的衡量指标,当使用每位患者的最低ICG-PDR时,AUC为0.815。对于入住重症监护病房(178例患者的数据),急性生理与慢性健康评估(APACHE)II的AUC为0.680,简化急性生理评分(SAPS)II的AUC为0.755,ICG-PDR的AUC为0.745。
ICG-PDR作为肝脏灌注和功能的标志物是危重病患者生存的良好预测指标:死亡率随ICG-PDR值降低而增加,非幸存者的ICG-PDR值显著低于幸存者。ICG-PDR在入住重症监护病房时对生存的敏感性和特异性与APACHE II和SAPS II评分相当。